Ameriprise Financial
AMP
$459.63
-1.90%
Ameriprise Financial, Inc. is a diversified financial services provider operating primarily in the asset management industry, with its core business centered on advice and wealth management, asset management through Columbia Threadneedle, and retirement and protection solutions. The company is a major US-based wealth manager, distinguished by its large scale with nearly $1.2 trillion in segment assets under management and advisory and a network of over 10,600 advisors. The current investor narrative revolves around its ability to navigate a potentially volatile market for asset management and advisory fees, with attention focused on the sustainability of its revenue growth and profitability in the face of economic uncertainty, as evidenced by recent quarterly performance and stock price volatility.…
AMP
Ameriprise Financial
$459.63
Investment Opinion: Should I buy AMP Today?
Rating & Thesis: Hold. Ameriprise presents a classic value trap scenario—fundamentally sound and cheap on earnings, but plagued by terrible momentum and market neglect. The core thesis is that the stock's deep valuation discount (forward P/E of 9.9x) is justified by its high volatility, earnings inconsistency, and severe underperformance, requiring patience for a catalyst to unlock value.
Supporting Evidence: The primary valuation metric, the forward P/E of 9.88x, is compelling for a company with an 18.8% net margin. Revenue growth remains positive at 8.3% YoY in Q4 2025, and profitability is robust with a trailing ROE of 54.4%. However, these strengths are counterbalanced by a price-to-book ratio of 7.1x, indicating the market values intangible assets highly, and a PEG ratio of 1.36, suggesting growth is not exceptionally cheap relative to the P/E. The stock offers a 6.5% dividend yield, but the high payout ratio of 84.9% limits growth potential.
Risks & Conditions: The two biggest risks are continued market underpressuring the multiple and a deterioration in AUM growth impacting future revenue. This Hold rating would upgrade to a Buy if the stock stabilizes above its 52-week low on sustained volume, the forward P/E compresses further towards 8x, or quarterly earnings demonstrate consistent sequential growth. It would downgrade to a Sell if revenue growth decelerates below 5% or the stock breaks decisively below the $422 support level. The stock is fairly valued relative to its own troubled recent history but appears undervalued on an absolute earnings basis.
Sign up to view all
AMP 12-Month Price Forecast
The outlook for AMP is one of high uncertainty with a neutral bias. The company's strong fundamentals and cheap valuation create a floor, but terrible momentum and sector headwinds create a ceiling. The base case of sideways consolidation is most probable, as the market will likely require multiple quarters of evidence before re-rating the stock. The stance would upgrade to bullish on a confirmed breakout above $500 on strong volume, signaling a break in the downtrend. It would downgrade to bearish on a close below $430, indicating a failure of the current support level and likely leading to a test of the 52-week low.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ameriprise Financial's 12-month outlook, with a consensus price target around $597.52 and implied upside of +30.0% versus the current price.
Average Target
$597.52
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$368 - $598
Analyst target range
Analyst coverage for Ameriprise appears limited based on the provided data, with only two analysts cited for estimates, indicating potentially insufficient coverage for a robust consensus view. The available data shows an estimated EPS average of $61.42 for an unspecified period, with a range from $56.26 to $64.10, and an estimated revenue average of $22.95 billion. Without a published consensus price target or recommendation distribution, it is challenging to quantify a clear bullish or bearish sentiment. The institutional ratings data shows recent actions, including a rating upgrade from Piper Sandler to 'Neutral' from 'Underweight' in January 2026, while firms like RBC Capital and Jefferies have maintained 'Outperform' and 'Buy' ratings, respectively. The presence of both 'Buy' and 'Underweight' ratings (from Morgan Stanley) signals divergent views among covering analysts. The implications of limited coverage suggest Ameriprise, despite its size, may have less consistent institutional analyst attention than mega-cap peers, which can contribute to higher volatility and less efficient price discovery.
Bulls vs Bears: AMP Investment Factors
The evidence presents a stark contrast: strong fundamental profitability and attractive valuation against severe technical underperformance and market skepticism. Currently, the bearish technical momentum and market sentiment hold stronger evidence, as the stock's deep underperformance and high volatility overshadow its solid financials. The single most important tension in the investment debate is whether the compellingly low valuation (forward P/E of 9.9x) will act as a magnet for value investors, or if the persistent negative momentum and sector headwinds will lead to further multiple compression. The resolution of this tension hinges on the company's ability to demonstrate stable earnings growth in the next few quarters to justify a valuation re-rating.
Bullish
- Strong Profitability & High ROE: Ameriprise demonstrates exceptional profitability with a trailing net margin of 18.8% and a Q4 2025 net margin of 19.9%. Its return on equity is an extremely high 54.4%, indicating highly efficient use of shareholder capital, though amplified by leverage.
- Attractive Valuation Multiples: The stock trades at a forward P/E of 9.88x and a trailing P/E of 13.05x, representing a significant discount from its historical highs above 26x. This forward multiple implies the market expects earnings growth and offers a compelling entry point for a profitable company.
- Solid Revenue Growth Trajectory: Q4 2025 revenue of $5.05 billion grew 8.3% year-over-year, continuing a multi-quarter growth trend from $4.33 billion in Q1 2024. This demonstrates resilience and growth in its core advice and wealth management business, which generates 65% of operating income.
- Robust Balance Sheet & Liquidity: The company maintains a strong current ratio of 7.87 and a manageable debt-to-equity ratio of 0.895. This financial strength provides a buffer against market volatility and supports its capital return policy, evidenced by an 84.9% payout ratio.
Bearish
- Severe Underperformance vs. Market: AMP has dramatically underperformed the broader market, with a 1-year relative strength of -36.7% versus the SPY. Its stock price is down 1.8% over the past year while the SPY gained 34.9%, indicating significant negative momentum and investor skepticism.
- High Volatility & Recent Sharp Decline: The stock has a beta of 1.266, making it 27% more volatile than the market, and has experienced a maximum drawdown of -21.1%. It currently trades 26.5% below its 52-week high of $550.18, reflecting substantial price erosion and heightened risk.
- Valuation Compression & Earnings Volatility: The trailing P/E has compressed from 26.07x in Q4 2023 to 13.05x currently, signaling a de-rating by the market. Quarterly net income has shown volatility, ranging from $583M in Q1 2025 to $1.07B in Q4 2024, raising concerns about earnings consistency.
- Limited Analyst Coverage & Divergent Views: Analyst coverage appears thin, with only two analysts providing estimates, which can lead to inefficient price discovery. Institutional ratings are mixed, ranging from 'Buy' to 'Underweight', reflecting uncertainty about the company's near-term prospects.
AMP Technical Analysis
The prevailing price trend for Ameriprise Financial has been a significant downtrend and consolidation over the observed period, with the stock posting a 1-year price change of -1.80% as of the latest data. The current price of $456.2 sits approximately 26.5% below its 52-week high of $550.18 and about 8.0% above its 52-week low of $422.37, positioning it in the lower-middle portion of its annual range, which suggests the stock has experienced a substantial correction from recent highs but is not at a deep value extreme. Recent short-term momentum shows a modest recovery attempt, with a 1-month price change of +5.47%, which contrasts sharply with the negative 3-month change of -10.43% and the negative year-to-date performance of -7.61%. This divergence, where the 1-month trend is positive against longer-term declines, could signal a potential stabilization or a bear market rally, but it remains weak relative to the broader market, as indicated by a negative 1-month relative strength of -1.89 versus the SPY. Key technical levels are clearly defined by the 52-week high of $550.18 as major resistance and the 52-week low of $422.37 as critical support; a sustained breakout above resistance would require a fundamental catalyst, while a breakdown below support could trigger further selling. The stock exhibits higher volatility than the market, with a beta of 1.266, meaning it is roughly 27% more volatile than the SPY, which is an important consideration for risk management given the stock's recent maximum drawdown of -21.1%.
Beta
1.27
1.27x market volatility
Max Drawdown
-21.1%
Largest decline past year
52-Week Range
$422-$550
Price range past year
Annual Return
-2.6%
Cumulative gain past year
| Period | AMP Return | S&P 500 |
|---|---|---|
| 1m | +2.6% | +8.5% |
| 3m | -7.4% | +2.8% |
| 6m | -4.1% | +4.6% |
| 1y | -2.6% | +32.3% |
| ytd | -6.9% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AMP Fundamental Analysis
Ameriprise's revenue trajectory shows solid growth, with Q4 2025 revenue of $5.05 billion representing an 8.3% year-over-year increase, and sequential growth from Q3's $4.87 billion. The multi-quarter trend reveals revenue has grown from $4.33 billion in Q1 2024 to the current level, indicating a generally positive growth path, though with some quarterly variability as seen in the dip in Q2 2025. Segment data reveals the Advice and Wealth Management segment is the dominant driver, contributing $3.38 billion, followed by Asset Management at $1.15 billion and Retirement and Protection Solutions at $1.09 billion. The company is highly profitable, reporting net income of $1.01 billion for Q4 2025, with a robust net margin of 19.9% for that quarter. Profitability metrics are strong, with a trailing twelve-month return on equity of 54.4% and a return on assets of 2.27%, indicating efficient use of capital. Margins have shown stability, with the Q4 2025 gross margin at 53.6% and operating margin at 27.2%, comparing favorably to the full-year valuation data showing a gross margin of 50.4% and operating margin of 25.5%. The balance sheet and cash flow position is mixed; the company maintains a strong current ratio of 7.87 and a manageable debt-to-equity ratio of 0.895. However, free cash flow generation appears volatile on a quarterly basis, with Q4 2025 showing negative operating and free cash flow, though the trailing twelve-month free cash flow is a positive $2.89 billion. The company's ROE of 54.4% is exceptionally high, but this is amplified by a significant equity multiplier, indicating substantial use of leverage within its financial structure.
Quarterly Revenue
$5.0B
2025-12
Revenue YoY Growth
+0.08%
YoY Comparison
Gross Margin
+0.53%
Latest Quarter
Free Cash Flow
$2.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AMP Overvalued?
Given the company's substantial positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. Ameriprise trades at a trailing PE of 13.05x and a forward PE of 9.88x based on available estimates. The gap between the trailing and forward multiples implies the market anticipates earnings growth, as the lower forward multiple suggests expected higher future earnings. Compared to industry averages, specific sector multiples are not provided in the data, but the stock's valuation can be assessed against its own history. Historically, the stock's PE ratio has fluctuated significantly, with recent quarterly data showing a PE of 11.53x at the end of Q4 2025, down from 20.45x in Q1 2025 and 26.07x in Q4 2023. The current trailing PE of 13.05x sits below the higher end of its recent historical range, suggesting the stock is not priced at peak optimism. The price-to-sales ratio of 2.46x and price-to-book ratio of 7.10x provide additional context, with the elevated PB ratio reflecting the market's valuation of its intangible assets and wealth management platform rather than tangible book value.
PE
13.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 7x~26x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Ameriprise's primary financial risk stems from its earnings volatility, as quarterly net income has fluctuated significantly, from $583 million to $1.07 billion over the past two years. While the company is highly profitable, its exceptionally high ROE of 54.4% is amplified by a significant equity multiplier, indicating reliance on financial leverage which can magnify losses in a downturn. Furthermore, revenue is concentrated in market-sensitive segments like Advice & Wealth Management (65% of operating income), making top-line growth vulnerable to equity market declines and client asset outflows.
Market & Competitive Risks: The stock faces substantial valuation compression risk, having already de-rated from a P/E of over 26x to 13x. Trading at a beta of 1.266, it is highly sensitive to broader market swings, and its severe underperformance suggests it is being penalized in the current market cycle. Competitive risks are inherent in the asset management industry, where fee pressure and the shift to passive investing could threaten the growth of its Columbia Threadneedle segment, which manages $678 billion in AUM.
Worst-Case Scenario: The worst-case scenario involves a sustained bear market combined with net outflows from its wealth management and asset management platforms. This would pressure the two primary revenue drivers simultaneously, leading to missed earnings estimates and further multiple compression. A realistic downside could see the stock re-testing its 52-week low of $422.37, representing a potential loss of approximately -7.4% from the current price of $456.2. A more severe scenario, factoring in the stock's high volatility and past drawdown of -21.1%, could see a decline towards $360, a loss of over -20%.
FAQ
The key risks are, in order of severity: 1) Market & Sentiment Risk: Persistent underperformance and high beta (1.27) make the stock vulnerable to further declines if financials fall out of favor. 2) Business Model Risk: Revenue is heavily tied to equity market levels and client AUM; a bear market directly hurts fees. 3) Earnings Volatility Risk: Quarterly net income has shown wide swings, creating uncertainty. 4) Leverage Risk: The exceptionally high ROE of 54.4% is supported by financial leverage, which can exacerbate losses in a downturn.
The 12-month forecast presents three scenarios. The base case (60% probability) sees the stock trading between $460 and $500, as it remains range-bound with depressed multiples. The bull case (25% probability) targets a recovery to $550-$580 on strong earnings and a market rally. The bear case (15% probability) warns of a decline to the $422-$440 range if support breaks amid market stress. The most likely outcome is the base case, predicated on the assumption that the current negative momentum persists but is offset by the stock's fundamental value, preventing a major new low.
AMP appears undervalued on an absolute earnings basis but fairly valued given its risk profile. Its forward P/E of 9.88x is low for a company with an 18.8% net margin and suggests the market is pricing in significant skepticism. Compared to its own history, where the P/E has traded above 26x, it is cheap. However, the elevated price-to-book ratio of 7.1x reflects the market's assessment of its intangible advisor network and brand. The valuation implies the market expects minimal growth and carries a high risk premium due to the stock's volatility and sector challenges.
AMP is a complex buy. For value investors seeking high profitability at a discount (forward P/E of 9.9x) and a 6.5% dividend yield, it presents a compelling case. However, for momentum or growth-oriented investors, it is a poor choice given its severe underperformance (-36.7% vs. SPY) and high volatility (beta of 1.27). It is a good buy only for those with a long-term horizon who can withstand further downside to its $422 support level while waiting for a fundamental or sentiment catalyst to unlock value.
AMP is unsuitable for short-term trading due to its high volatility (beta 1.27) and lack of positive momentum. It is best considered a long-term investment for investors willing to hold for a minimum of 2-3 years to potentially realize the value embedded in its low P/E and high dividend yield. The long-term thesis depends on the company's ability to consistently grow AUM and earnings, which will take time to convince the market. The 6.5% dividend yield provides some compensation for the wait, but the stock's characteristics do not support a short-term horizon.
